ReviewJournal of hematology & oncology2017

MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer.

Veronica Tisato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.